Pneumococcal vaccines formulated with interleukin-12
US6709658B1 · kind B1 · utility
3Cited by
4References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 10, 1999 |
| Grant date | Mar 23, 2004 |
| Priority date | — |
| Expiry date | Feb 10, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/6037
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention pertains to vaccine compositions comprising a mixture of antigen, such as a pneumococcal or meningococcal antigen, and interleukin IL-12, which may be adsorbed onto a mineral in suspension. The pneumococcal or meningococcal antigen may be conjugated to a carrier molecule. These vaccine compositions modulate the protective immune response to the antigen.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.